596 filings
8-K
GYRE
Gyre Therapeutics Inc
9 May 24
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
4:05pm
8-K
GYRE
Gyre Therapeutics Inc
8 May 24
Regulation FD Disclosure
8:00am
ARS
2023 FY
GYRE
Gyre Therapeutics Inc
29 Apr 24
Annual report to shareholders
8:49am
DEFA14A
GYRE
Gyre Therapeutics Inc
29 Apr 24
Additional proxy soliciting materials
8:48am
DEF 14A
GYRE
Gyre Therapeutics Inc
Definitive proxy
29 Apr 24
8:46am
S-8
pw4s6 yc82mj18hsxw0o
27 Mar 24
Registration of securities for employees
9:00pm
8-K
8x8sn9
26 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:03pm
8-K
2jo1r9v2kobg 9wl
25 Mar 24
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
9:55pm
8-K
2wn7p9v7is6mlfz
21 Mar 24
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
7:15am
8-K
30b 6m3xrt25htklnj2d
14 Feb 24
Results of Operations and Financial Condition
5:16pm
8-K/A
rpji92 a3r
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K/A
dag ekoaiok6bjq
12 Jan 24
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
vvl3ugkcs bwm
15 Dec 23
Departure of Directors or Certain Officers
4:21pm
8-K
cn30kmwh6k jhstu4c2
6 Dec 23
Regulation FD Disclosure
4:01pm
RW
21xny4r yk3uncv2
29 Nov 23
Registration withdrawal request
4:01pm
8-K
qtl1j7a06iyzdeca nq
14 Nov 23
Regulation FD Disclosure
12:00am
D
od7wrp
13 Nov 23
$5.00 mm in equity / options, sold $5.00 mm, 1 investor
5:13pm
8-K
7j4m7 cqn0
13 Nov 23
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
7:01am